Prognostic features in non-TCGA IDH1/2-mutant 1p/19q-codeleted oligodendrogliomas were rare and no molecular alterations significantly influenced survival, including MGMT-methylation status. This evidence concerns the gene IDH1 and oligodendroglioma.